Sclerostin antibody (N-Term)
Quick Overview for Sclerostin antibody (N-Term) (ABIN390193)
Target
See all Sclerostin (SOST) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
- 
    
- 
                                            
Binding Specificity
 - AA 12-42, N-Term
 - 
                                            
Predicted Reactivity
 - B
 - 
                                            
Purification
 - This antibody is purified through a protein A column, followed by peptide affinity purification.
 - 
                                            
Immunogen
 - This SOST antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 12-42 amino acids from the N-terminal region of human SOST.
 - 
                                            
Isotype
 - IgG
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Application Notes
 - WB: 1:1000. WB: 1:2000. WB: 1:1000. WB: 1:2000. IHC-P-Leica: 1:500
 - 
                                            
Restrictions
 - For Research Use only
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Liquid
 - 
                                            
Buffer
 - Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
 - 
                                            
Preservative
 - Sodium azide
 - 
                                            
Precaution of Use
 - This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 - 
                                            
Handling Advice
 - Avoid freeze-thaw cycles.
 - 
                                            
Storage
 - 4 °C,-20 °C
 - 
                                            
Storage Comment
 - Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots.
 - 
                                            
Expiry Date
 - 6 months
 
 - 
                                            
 - 
    
- 
                                            : "Co-expression of DKK-1 and Sclerostin in Subchondral Bone of the Proximal Femoral Heads from Osteoarthritic Hips."    in: Calcified tissue international, Vol. 100, Issue 6, pp. 609-618, (2018)         (PubMed).        
: "Single-pulsed electromagnetic field therapy increases osteogenic differentiation through Wnt signaling pathway and sclerostin downregulation." in: Bioelectromagnetics, Vol. 36, Issue 7, pp. 494-505, (2015) (PubMed).
 
 - 
                                            : "Co-expression of DKK-1 and Sclerostin in Subchondral Bone of the Proximal Femoral Heads from Osteoarthritic Hips."    in: Calcified tissue international, Vol. 100, Issue 6, pp. 609-618, (2018)         (PubMed).        
 - 
    
- Sclerostin (SOST)
 - 
                                            
Alternative Name
 - SOST
 - 
                                            
Background
 - Sclerostin is a secreted glycoprotein with a C-terminal cysteine knot-like (CTCK) domain and sequence similarity to the DAN (differential screening-selected gene aberrative in neuroblastoma) family of bone morphogenetic protein (BMP) antagonists. Loss-of-function mutations in this gene are associated with an autosomal-recessive disorder, sclerosteosis, which causes progressive bone overgrowth. A deletion downstream of this gene, which causes reduced sclerostin expression, is associated with a milder form of the disorder called van Buchem disease.
 - 
                                            
Molecular Weight
 - 24031
 - 
                                            
Gene ID
 - 50964
 - 
                                            
NCBI Accession
 - NP_079513
 - 
                                            
UniProt
 - Q9BQB4
 
Target
 -